Arcturus Therapeutics Holdings, Inc. (ARCT)
6.80
+0.03
(+0.44%)
USD |
NASDAQ |
Jan 09, 13:10
Arcturus Therapeutics Holdings Research and Development Expense (Annual): 124.69M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | 77.22M |
| Perspective Therapeutics, Inc. | 39.33M |
| Novavax, Inc. | 388.77M |
| Sangamo Therapeutics, Inc. | 111.28M |
| Myomo, Inc. | 4.772M |